Saturday, May 18, 2024

June 13, 2000: Congressional Record publishes “Senate Committee Meetings”

Volume 146, No. 73 covering the 2nd Session of the 106th Congress (1999 - 2000) was published by the Congressional Record.

The Congressional Record is a unique source of public documentation. It started in 1873, documenting nearly all the major and minor policies being discussed and debated.

“Senate Committee Meetings” mentioning the Environmental Protection Agency was published in the Daily Digest section on pages D583-D585 on June 13, 2000.

The publication is reproduced in full below:

Committee Meetings

(Committees not listed did not meet)

APPROPRIATIONS--TRANSPORTATION

Committee on Appropriations: Committee ordered favorably reported an original bill, making appropriations for the Department of Transportation and related agencies for the fiscal year ending September 30, 2001.

APPROPRIATION--DISTRICT OF COLUMBIA

Committee on Appropriations: Subcommittee on District of Columbia concluded hearings on proposed budget estimates for fiscal year 2001 for the District of Columbia, after receiving testimony from Mayor Anthony A. Williams, Linda W. Cropp, Chairman, Council of the District of Columbia, and Alice M. Rivlin, Chairman, District of Columbia Financial Responsibility and Management Assistance Authority, all of Washington, D.C.

APPROPRIATIONS--TRANSPORTATION

Committee on Appropriations: Subcommittee on Transportation approved for full committee consideration an original bill, making appropriations for the Department of Transportation and related agencies for the fiscal year ending September 30, 2001.

MERCHANT BANKING ACTIVITIES

Committee on Banking, Housing, and Urban Affairs: Subcommittee on Financial Institutions and Subcommittee on Securities concluded joint hearings to examine the regulation of merchant banking activities under the Gramm-Leach-Bliley Act of 1999, after receiving testimony from Gary Gensler, Under Secretary of the Treasury for Domestic Finance; Lawrence H. Meyer, Member, Board of Governors, Federal Reserve System; Frederick M. Fritz, BancBoston Capital, Boston, Massachusetts, and Jeffrey Walker, Chase Capital Partners, New York, New York, both on behalf of the Financial Services Roundtable; Marc E. Lackritz, Securities Industry Association, and Joseph S. Bracewell, Century National Bank, on behalf of the Independent Community Bankers of America, both of Washington, D.C.; and John P. Whaley, Norwest Equity Partners and Norwest Venture Partners, Minneapolis, Minnesota, on behalf of the American Bankers Association and American Bankers Association Securities Association.

ONLINE PROFILING AND PRIVACY

Committee on Commerce, Science, and Transportation: Committee concluded hearings to examine online profiling done by Internet network advertisers and how it impacts consumer's privacy, after receiving testimony from Jodie Bernstein, Director, Bureau of Consumer Protection, and David Medine, Associate Director for Financial Practices, both of the Federal Trade Commission; Jules Polonetsky, DoubleClick, New York, New York; Daniel Jaye, Engage, Inc., Andover, Massachusetts; Marc Rotenberg, Electronic Privacy Information Center, Washington, D.C.; and Richard M. Smith, Brookline, Massachusetts.

NOMINATIONS

Committee on Environment and Public Works: Committee concluded hearings on the nominations of James V. Aidala, of Virginia, to be Assistant Administrator for Toxic Substances of the Environmental Protection Agency, Arthur C. Campbell, of Tennessee, to be Assistant Secretary of Commerce for Economic Development, and Ella Wong-Rusinko, of Virginia, to be Alternate Federal Co-chairman of the Appalachian Regional Commission, after the nominees testified and answered questions in their own behalf. Mr. Aidala was introduced by Senators Lieberman and Roberts, Mr. Campbell was introduced by Senator Frist and Representatives Bennie Thompson and Wamp, and Ms. Wong-Rusinko was introduced by Senators Warner and Hutchison.

TIBET

Committee on Foreign Relations: Subcommittee on East Asian and Pacific Affairs concluded hearings to examine recent developments in promoting a positive Tibetan/Chinese relationship, while sustaining Tibet's unique religious, linguistic, and cultural heritage, after receiving testimony from Julia V. Taft, Special Coordinator for Tibet, Department of State; John Ackerly, International Campaign for Tibet, Washington, D.C.; Elliot Spurling, Indiana University Department of Central Eurasian Studies, Bloomington, on behalf of the Human Rights Watch; and Elizabeth Napper, Tibetan Nuns' Project, San Geronimo, California.

POST-CONVICTION DNA TESTING

Committee on the Judiciary: Committee concluded hearings on post-

conviction DNA testing, focusing on how to incorporate DNA testing more fully into the American criminal justice system, and related proposals, after receiving testimony from Oklahoma Attorney General W.A. Drew Edmondson, Oklahoma City; New York State Attorney General Eliot Spitzer, New York; California Deputy Attorney General Enid A. Camps, Sacramento; Charles F. Baird, former Judge, Texas Court of Criminal Appeals, Austin, on behalf of the National Committee to Prevent Wrongful Executions; Joshua K. Marquis, Clatsop County District Attorney, Astoria, Oregon, on behalf of the National District Attorney's Association; Barry C. Scheck, Benjamin N. Cardozo School of Law, New York, New York, on behalf of the Innocence Project, George Clarke, San Diego County Deputy District Attorney, California, and James Wooley, Baker and Hostetler, Case Western Reserve University Law School, Washington, D.C., all on behalf of the National Commission on the Future of DNA Testing; Bryan A. Stevenson, New York University School of Law, New York, on behalf of the Equal Justice Initiative of Alabama; and Dennis Fritz, Kansas City, Missouri.

PRESCRIPTION DRUG SAFETY AND PRICING

Committee on Health, Education, Labor, and Pensions: Committee concluded hearings to examine the accessibility of affordable prescription drugs, the price differentials for identical prescription drugs in the international marketplace, and drug quality and safety, after receiving testimony from Senators Gorton, Dorgan, Johnson, and Burns; Representative Sanders; Christopher T. Rhodes, University of Rhode Island, Kingston; Patricia M. Danzon, University of Pennsylvania Wharton School of Management, Philadelphia; Stephen W. Schondelmeyer, University of Minnesota College of Pharmacy PRIME Institute, Minneapolis; Ronald F. Pollack, Families USA, and Alan F. Holmer, Pharmaceutical Research and Manufacturers of America, both of Washington, D.C.; and Paul Abrams, NeoRx Corporation, Seattle, Washington, on behalf of the Biotechnology Industry Organization.

SOURCE: Congressional Record Vol. 146, No. 73